Chapel Hill, NC (919) 933-2000 Charlotte, NC (704) 529-4101 Raleigh, NC (919) 785-5055

Publications, Presentations, and Research

Publications by Gualtieri, C.T.

“Mild Cognitive Disorders”

The following six chapters are draft chapters that will appear, in a year or so, in our new book, Mild Cognitive Disorders. Your comments and recommendations are welcome. You may cite them as you please by referencing our website.

A. Intro:  Normal Aging, MCI and the Dementias

Resources for Patients / Frequently Referenced

  • Gualtieri, C.T. (2004). Antidepressant side effects in Children and Adolescents. Download PDF
  • Gualtieri, C.T. (2002). Cognitive enhancers and neuroprotectants. In Brain Injury and Mental Retardation (pp. 429 - 448). Philadelphia, PA: Lippincott Williams & Wilkins. Download PDF

Recent Publications, Presentations, and Research

  • C Thomas Gualtieri MD, Lynda G Johnson, PhD Neurocognition In Depression: Patients On And Off Medication, Compared To Normal Controls. In press - The Journal of Neuropsychiatry and Clinical Neurosciences. Download Abstract (PDF)
  • C Thomas Gualtieri MD, Lynda G Johnson, PhD Differentiating Between Mild Cognitive Impairment And Early Dementia With A New, Computerized Neurocognitive Screening Battery. Alzheimer's Association International Conference on Prevention of Dementia, Washington DC, June, 2005. Download Abstract (PDF)
  • C Thomas Gualtieri MD, Lynda G Johnson, PhD Comparative Neurocognitive Effects of Five Psychotropic Anticonvulsants And Lithium. American Psychiatric Association Annual Meeting, Atlanta, May 26, 2005. Download Abstract (PDF)
  • C Thomas Gualtieri MD, Lynda G Johnson, PhD Neurocognitive Testing Supports a Broader Concept of Mild Cognitive Impairment. American Psychiatric Association Annual Meeting, Atlanta, May 26, 2005. Download Abstract (PDF)
  • Gualtieri, C.T., Johnson, L.G., & Benedict, K.B. Reliability and validity of a new computerized cognitive screening battery. International Neuropsychological Society, Annual Meeting, Baltimore, MD Feb. 4-7, 2004. Download PDF
  • Gualtieri, C.T., Johnson, L.G., & Benedict, K.B. Cognitive performance in bipolar and unipolar depression. International Neuropsychological Society, Annual Meeting, Baltimore, MD Feb. 4-7, 2004. Download PDF
  • Gualtieri, C.T., Johnson, L.G., & Benedict, K.B. Drug sensitivity of a computerized neurocognitive test battery. International Neuropsychological Society, Annual Meeting, Baltimore, MD Feb. 4-7, 2004. Download PDF
  • Gualtieri, C.T., Johnson, L.G., & Benedict, K.B. Psychometric and clinical properties of a new, computerized neurocognitive screening battery. American Neuropsychiatric Association Annual Meeting, Bal Harbor, FL Feb. 24, 2004. Download PDF
  • Gualtieri, C.T., Johnson, L.G., & Benedict, K.B. A Computerized cognitive screening battery for psychiatrists. American Psychiatric Association, Annual Meeting, New York, NY May 2004. Download PDF
  • Gualtieri, C.T., Johnson, L.G., & Benedict, K.B. The comparative neurocognitive effects of seven antidepressants. American Psychiatric Association, Annual Meeting, New York, NY May 2004. Download Abstract (PDF)
  • C Thomas Gualtieri MD, Lynda G Johnson, PhD, Molly Beam BA. Differentiating Between Mild Cognitive Impairment And Early Dementia With A New, Computerized Neurocognitive Screening Battery. 7th International Alzheimer's Association Conference, Philadelphia, 2004. Download Abstract (PDF)
  • Gualtieri, C.T. Computerized neurocognitive test batteries for dementia screening. Alzheimer's Association, 9th International Conference on Alzheimer's Disease and Related Disorders. July 2004. Download PDF
  • Gualtieri, C.T. (2004). Dementia screening in light of the diversity of the condition. Journal of Insurance Medicine. J Insur Med 2004;36:298-309
  • Gualtieri, C.T. (2004). Dementia screening Using Computerized Tests. Journal of Insurance Medicine. J Insur Med 2004;36:213-227

Monographs

  • Gualtieri, C.T. Neuropsychiatry and Behavioral Psychopharmacology. Springer Verlag: Berlin, 1990.
  • Gualtieri, C.T. Mental Retardation. Psychiatric Treatment Manual, Volume 1. American Psychiatric Press, Washington, DC, 1988.
  • Gualtieri, C.T. Neuropsychiatry and the Pharmacology of Behavior. I. The Psychopharmacology of Extraordinary Conditions.
  • Gualtieri, C.T. Neuropsychiatry and the Pharmacology of Behavior. II. The Psychopharmacology of Everyday Life.

AD/HD and Stimulant Drugs

  • * Gualtieri, C.T., Kanoy, R., Hawk, B., Koriath, U., Schroeder, S.R., Youngblood, W., Breese, G. & Prange, A.J. (1981) Growth hormone and prolactin secretion in adults and hyperactive children: Relation to methylphenidate blood levels. Psycho-neuroendocrinology, 6, 331-339.
  • Breese, G., Gualtieri, C.T., Mailman, R., Mueller, R., Youngblood, W., Bogel, R. & Wilson, J. (1981) Developmental neuropsychopharmacology: Preclinical and clinical studies of the hyperkinetic syndrome. In: A. Raskin, D. Robinson & J. Levine (Eds), Age and the pharmacology of psychoactive drugs, New York: Elsevier, pp. 63-78.
  • * Gualtieri, C.T., Wargin, W., Kanoy, R., Shen, C., Patrick, K., Youngblood, W., Mueller, R. & Breese, G. (1982) Clinical Studies of Methylphenidate Serum Levels in Children and Adults. Journal of American Academy of Child Psychiatry, 21, 19-26.
  • * Gualtieri, C.T., Wargin, W., Kanoy, R., Youngblood, W. & Breese, G. (1982) The effects of eating and fasting on the absorption of methylphenidate. Research Communications in Psychiatry, Psychology & Behavior, 7, 381-384.
  • * Gualtieri, C.T., Hicks. R.E., Mayo, J.P. (1983) Hyperactivity and Homeostasis. Journal of American Academy of Child Psychiatry, 22, 382-384.
  • * Wargin, W., Patrick, K., Kilts, C., Gualtieri, C.T., Ellington, K., Mueller, R., Kramer, G. & Breese, G. (1983) Pharmacokinetics of methylphenidate in man, rat and monkey. Journal of Pharmacotherapy and Experimental Therapeutics, 226, 382-386.
  • * Gualtieri, C.T., Hicks, R.E., Mayo, J.P., Schroeder, S.R. & Lipton, M.A. (1984) The persistence of stimulant effects in chronically treated children: Further evidence of an inverse relationship between drug effects and placebo levels of response. Psychopharmacology, 83, 44-47.
  • * Gualtieri, C.T., Hicks, R.E., Patrick, K., Schroeder, S.R. & Breese, G.(1984) Clinical correlates of methylphenidate blood levels. Therapeutic Drug Monitoring, 6, 379-392.
  • * Koriath, U., Gualtieri, C.T., Van Bourgondien, M.E., Quade, D. & Werry, J.S. (1985) Construct Validity of Clinical Diagnosis in Pediatric Psychiatry: Relationship Among Measures. Journal of American Academy of Child Psychiatry, 24(4), 429-436.
  • Hicks, R.E., Gualtieri, C.T., Mayo, J.P., Schroeder, S.R. & Lipton, M.A. (1985) Methylphenidate and Homeostasis: Drug Effects on the Cognitive Performance of Hyperactive Children. In: L.M. Bloomingdale (Ed), Attention Deficit Disorder II, Identification, Course and Rationale, New York: Spectrum Press, pp. 131-143.
  • Gualtieri, C.T. & Hicks, R.E. (1985) Stimulants and Neuroleptics in Hyperactive Children (Letter to the Editor). Journal of American Academy of Child Psychiatry, 24(3).
  • * Gualtieri, C.T., Ondrusek, M.G. 7 Finley, C. (1985) Attention Deficit Disorder in Adults. Clinical Neuropharmacology, 8(4), 343-356.
  • Gualtieri, C.T. & Hicks, R.E., (1986) The Neuropharmacology of Methylphenidate and a Neural Substrate for Childhood Hyperactivity. Psychiatric Clinics of North America, 8(4), 875-892. Reprinted (1987) in Chess & Thomas (eds) Annual Progress in Child Psychiatry and Child Development.
  • * Gualtieri, C.T., Hicks, R.E., Levitt, J., Conley, R. & Schroeder, S.R. (1986) Methylphenidate & Exercise: Additive Effects on Motor Performance, Variable Effects on the Neuroendocrine Response. Neuropsychobiology, 15, 84-88.
  • * Evans, R.W., Amara, I. & Gualtieri, C.T. (1986) Methylphenidate and Memory: Dissociated Effects in Hyperactive Children. Psychopharmacology, 90(2), 211-216.
  • Evans, R.W., Gualtieri, C.T. & Shear, P.K. (1987) Childhood Hyperactivity. In: B. Epanchin & J. Paul (eds), Emotional Problems of Childhood and Adolescence, Merrill Publishing: Columbus, OH, 143-161.
  • * Evans, R.W., Gualtieri, C.T. & Hicks, R.E. (1986) Neuropathic Substrate for Stimulant Drug Effects in Hyperactive Children. Clinical Neuropharmacology, 9(3), 264-281.
  • * Schroeder, S.R., Mann-Koepke, K., Gualtieri, C.T., Eckermann, D.A. & Breese, G.R. (1987) Methylphenidate Affects Strategic Choice Behavior in Normal Adult Humans. Pharmacology, Biochemistry & Behavior, 28, 213-217.
  • Chandler, M.C. & Gualtieri, C.T. (1988) Other Psychotropic Drugs: Stimulants, Antidepressants, Lithium and the Anxiolytics. In: M.G. Aman (ed), Psychopharmacology of Developmental Disabilities, Springer-Verlag, Berlin.
  • Patrick, K.S., Mueller, R.A., Gualtieri, C.T. & Breese, G.R. (1988) Pharmacokinetics and Actions of Methylphenidate. In: H. Meltzer, R. Shader & R.Greenblatt (eds) Psychopharmacology: Third Generation of Progress. New York: Raven Press, 1387-1397.
  • * Chandler, M.C., Barnhill, L.J., Gualtieri, C.T., Patterson, D.R. (1989) Tryptophan Antagonism of Stimulant-Induced Tics. J. Clinical Psychopharmacology, 9(1), p. 69.
  • * Gualtieri, C.T., P.A. Keenan, and M. Chandler. 1991. Clinical and neuropsychological effects of desipramine in children with attention deficit hyperactivity disorder. J Clin Psychopharmacol 11:155-159.
  • * Conners,C.K., Casat,C.D., Ascher,J.A., Gualtieri,C.T., Weller,E., Khayrallah,M., Samara,B., Johnston,J.A., Lineberry,C.G.. (1997) Bupropion hydrochloride in attention deficit disorder with hyperactivity, in press.
  • Jabbour, J.T., Jones, R.C., Bulten, R.G., Harris, R.C., Boehm, R.M., Wilhelm, D.J., Lesser, P.S., Waugh, L.D., Farrell, S.E., Eastmead, D.J., Gualtieri, C.T., Browne, R.G., (1997) Adderall in the Treatment of Attention Deficit Hyperactivity Disorder: A Multi-Center Study, Ms submitted.

Tardive Dyskinesia and Neuroleptic Drugs

  • * Gualtieri, C.T., Barnhill, L.J., McGimsey, J. & Shell, D. (1980) Tardive dyskinesia and other drug-induced movement disorders in children. Journal of American Academy of Child Psychiatry, 19, 491-510.
  • * Gualtieri, C.T. & Hawk, B. (1980) Tardive dyskinesia and other drug-induced movement disorders among handicapped children and youth. Journal of Applied Research and Mental Retardation, 1, 55-69. Reprinted (1982) in Chess and Thomas (eds), Annual Progress in Child Psychiatry and Child Development.
  • * Gualtieri, C.T., Rojahn, J. & Staye, J. (1980) The influence of neuroleptic drugs on prolactin secretion in children. Developmental Medicine and Child Neurology, 23, 255-259.
  • *Gualtieri, C.T. and Guimond, M. (1981) Tardive dyskinesia and the behavioral consequences of chronic neuroleptic treatment. Developmental Medicine and Child Neurology, 23, 255, 259.
  • * Gualtieri, C.T., Lefler, W.H., Guimond, M. & Staye, J. (1982) Corneal and lenticular opacities in mentally retarded young adults treated with thioridazine and chlorpromazine. American Journal of Psychiatry, 139, 1178-1180.
  • * Gualtieri, C.T., Quade, D., Hicks, R.E. & Schroeder, S.R. (1984) Tardive dyskinesia and the clinical consequences of neuroleptic treatment in children and adolescents. American Journal of Psychiatry, 141, 21-23. Abstracted in Psychiatry Digest.
  • Gualtieri, C.T. & Sprague, R.L. (1984) Preventing tardive dyskinesia and preventing tardive dyskinesia litigation. Psychopharmacology Bulletin, 20(3), 346-348.
  • Gualtieri, C.T. (1985) The Problem of Tardive Dyskinesia Litigation. Psychiatric Aspects of Mental Retardation Reviews, 4(4), 12-16, April.
  • Schroeder S.R. & Gualtieri, C.T. (1985) Behavioral interactions induced by chronic neuroleptic therapy in persons with mental retardation. Psychopharmacology Bulletin, 21, 310-315.
  • Gualtieri, C.T., Keppel, J.M. & Schroeder, S.R. (1986) Tardive Dyskinesia: New Facts and New Recommendations. Psychiatric Aspects of Mental Retardation Reviews, 5(1), 1-6.
  • * Gualtieri, C.T., Schroeder, S.R., Hicks, R.E. & Quade, D. (1986) Tardive dyskinesia in young mentally retarded individuals. Archives of General Psychiatry, 43, 335-340.
  • * Gualtieri, C.T. & Patterson, D.R. (1986) Neuroleptic-Induced Tics. American Journal of Psychiatry, 143(9), 1176-1177.
  • * Gualtieri, C.T., Sprague, R.L., Cole, J.O. & Liption, M.A. (1986) Tardive dyskinesia litigation & the dilemmas of neuroleptic treatment. The Journal of Psychiatry and the Law, 14(1-2), 187-216.
  • American Psychiatric Association (1992) Task Force Report on Tardive Dyskinesia. American Psychiatric Press, Washington.
  • Gualtieri, C.T. & Barnhill, L.J. (1988) Tardive Dyskinesia in Special Populations. In: M. Wolf (ed), Biological Mechanisms & Clinical Aspects, American Psychiatric Press, Washington. pp 137-54.
  • Richmond, G., Bell, J., Brown, D.K., Kissel, R.C., Gualtieri, C.T. & Schroeder, S.R. (1987) Changes in Severity of Tardive Dyskinesia in the Retarded During Follow-up Neuroleptic Withdrawal. (Unpub)
  • Gualtieri, C.T. & Sovner, R.M. (1989) Tardive Akathisia. Psychiatric Aspects of Mental Retardation Reviews, 8, 83-90.
  • Gualtieri, C.T. (1991) TMS: A system for Prevention and Control. In J Ratey (Ed), Mental Retardation: Developing Pharamcotherapies, American Psychiatric Press, Washington, pp 35-50.
  • * Gualtieri, C.T., N. Sanders, and N. Leslie. (1993). The problem of tardive akathisia. Brain and Cognition, 23, 102-109.
  • Gualtieri, C.T., N. Leslie, and N. Sanders. 1993. Tardive Akathisia: Prevalence and Validation. (UnPub)

Psychopharmacology

  • * Gualtieri, C.T. (1977) Imipramine and children: A review and some speculations on the mechanism of drug action.Diseases of the Nervous System, 38, 368-375.
  • * Gualtieri, C.T. & Powell, S.F. (1978) Psychoactive drug interactions. Journal of Clinical Psychiatry, 39, 720-729.
  • * Gualtieri, C.T. & Staye, J. (1979) Withdrawal symptoms after abrupt cessation of amitryptiline in an eight-year old boy. American Journal of Psychiatry, 136, 1201-1203.
  • * Linoilla, M., Gualtieri, C.T. & Jobson, J. (1980) Therapeutic characteristics of imipramine response in hyperactive children. Journal of American Academy of Child and Adolescent Psychiatry, 19, 491-510.
  • Gualtieri, C.T. & Hawk, B. (1981) Clinical guide to pediatric psychopharmacology. In: S. Gabel (ed), Behavioral Problems in Childhood. New York: Gune & Stratton, pp. 409-424.
  • Gualtieri, C.T. & Hawk, B. (1982) Antidepressant drugs and lithium salts in the treatment of the mentally retarded. In: S. Breuning & A.D. Poling (eds), Drugs and Mental Retardation. New York: Charles C. Thomas Press, pp. 215-234.
  • * Gualtieri, C.T., Golden, R. & Fahs, J. (1983) New developments in pediatric psychopharmacology. Journal of Developmental and Behavioral Pediatrics, 4, 202-208.
  • Golden, R.N. & Gualtieri, C.T. (1983) Clinician's guide to the new antidepressants. Resident & Staff Physician, 29, 65-72. Reprinted in Medical Times, 111, 101-107.
  • * Gualtieri, C.T., Golden, R. Wargin, W. & Breese, G. (1984) Blood level measurement of psychoactive drugs in pediatric psychiatry, Therapeutic Drug Monitoring, 6, 127-141.
  • * Evans, R.W. & Gualtieri, C.T. (1985) Carbamazepine: A Neuropsychological & Psychiatric Profile. Clinical Neuropharmacology, 8(3), 221-241.
  • * Evans, R.W., Clay, T. & Gualtieri, C.T. (1987) Carbamazepine in Pediatric Psychiatry. Journal of American Academy of Child and Adolescent Psychiatry, 26(1), 2-8. Abstracted in Psychiatry Digest, (1987) 5, 11-12. Reprinted in the Yearbook of Psychiatry and Applied Mental Health.
  • Evans, R.W., Amara, I. & Gualtieri, C.T. (1986) Piracetam and Memory Functions: Preliminary Negative Findings. (Unpub)
  • * Evans, R.W. & Gualtieri, C.T. (1988) Motor Performance in Hyperactive Children Treated with Imipramine. Perceptual and Motor Skills, 66, 763-769.
  • Clay, T.H., Guillon, C.M., Gualtieri, C.T. & Evans, R.W. (1988) Clinical and Neuropsychological Effects of the Novel Antidepressant, Bupropion. Psychopharmacology Bulletin, 24(1), 143-148.
  • Gualtieri, C.T. (1991). Paradoxical effects of fluoxetine. J Clin Psychopharmacol, 11, 393-394.
  • Gualtieri,C.T., Bach-y-Rita,P.R. (1997). Non-synaptic Diffusion Neurotransmission: Mood, Fuzzy Logic and Drug Effects. Ms submitted.

Neuropsychiatry / Neuropsychology

  • * Hicks, R.E., Schroeder, S.R. & Gualtieri, C.T. (1982) Effects of response language and stiumuls context upon judgements of visual and temporal extent. American Journal of Psychology, 96, 382-384.
  • * Hicks, R.E., Gualtieri, C.T. & Schroeder, S.R. (1983) Cognitive and motor components of bilateral transfer. American Journal of Psychology, 96, 365-375.
  • * Hicks, R.E., Perez-Reyes, M., Mayo, J.P. & Gualtieri, C.T. (1984) Cannabis, Atropine and Temporal Information Processing. Neuropsychobiology, 12, 229-237.
  • * Evans, R.W., Ruff, R.M. & Gualtieri, C.T. (1985) Verbal Fluency & Figural Fluency in Bright Children. Perceptual Motor Skills, 61, 699-709.
  • * Hicks, R.E., Kinsbourne, M. & Gualtieri, C.T. (1985) Response processes in judgmental contrast. Journal of General Psychology, 112, 79-89.
  • * Evans, R.W., Gualtieri, C.T. & Ruff, R.M. (1986) Alternative Selective Reminding Forms for Children. Developmental Neuropsychology, 2(2), 137-144.
  • * Evans, R.W., Gualtieri, C.T. & Patterson, D.R. (1986) Treatment of Chronic Closed Head injury with Psychostimulant Drugs: A Controlled Case Study and An Appropriate Evaluation Procedure. Journal Nervous & Mental Disease, 175(2), 106-110.
  • * Evans, R.W. & Gualtieri, C.T. (1987) Psychostimulant Pharmacology in Traumatic Brain Injury. Journal of Head Trauma Rehabilitation, 2(4), 29-33.
  • * Gualtieri, C.T. (1988) Pharmacotherapy and the Neurobehavioral Sequelae of Traumatic Brain Injury. Brain Injury, 2(2), 101-129.
  • Gualtieri, C.T. & Evans, R.W. (1988) Stimulant Treatment of Closed Head Injury Patients: Controlled Trial. Brain Injury, 2, 273-290.
  • * Barnhill, L.J. & Gualtieri, C.T. (1989) Late-Onset Psychosis Following Head Injury. Neuropsychiatry, Neuropsychology & Behavioral Pharmacology, 2, 211-218, 1989.
  • * Chandler, M.C., Barnhill, L.J., Gualtieri, C.T. (1988) Amantadine for the Agitated Head-Injury Patient. Brain Injury, 2(4), 309-311.
  • Gualtieri, C.T., Nygard, N.K. (1988) Rehabilitation of 'Poor Prognosis' Head Injuries. Rebound Quarterly Research Report, 1(2), 4-5.
  • Gualtieri, C.T., Evans, R.W. (1988) Use of a Stimulant with Brain Injured Clients. Rebound Quarterly Research Report, 1(2), 6-8.
  • Gualtieri, C.T., Nygard, N.K. (1988) Rehabilitation for Head Injury, Five Years after the Event. Rebound Quarterly Research Report, 1(2), 16-26.
  • Gualtieri, C.T., Nygard, N.K. (1988) Stimulant Treatment for the Neurobehavioral Sequelae of Traumatic Brain Injury. Rebound Quarterly Research Report, 1(2), 27-40.
  • * Gualtieri, C.T., Chandler, M.L., Coons, T., & Brown, L. (1989) Amantadine: A New Clinical Profile for Traumatic Brain Injury. Journal of Clinical Neuropharmacology, 12, 258-270.
  • Gualtieri, C.T. (1991) Psychostimulants in Traumatic Brain Injury. In L. Greenhill & B.B. Osman (Eds), Ritalin: Theory and Patient Management, Mary Ann Liebert, New York, pp 171-176.
  • * Gualtieri, C.T. (1991) Buspirone. Journal of Head Injury Rehabilitation, 6:90-92.
  • * Gualtieri, C.T. (1990) Inadvertent Drug Effects in Traumatic Brain Injury, Journal of Head Injury Rehabilitation, 5:32-40.
  • * Gualtieri, C.T. 1990. The neuropsychiatric sequelae of traumatic brain injury. Journal of Child and Adolescent Psychopharmacology 1:149-152.
  • * Gualtieri,C.T. & Cox, D. (1991) Delayed Neurobehavioral Sequellae of Traumatic Brain Injury. Brain Injury 5:219-232.
  • * Blackerby, W.F., and C.T. Gualtieri. 1991. Recent advances in neurobehavioral rehabilitation. NeuroRehabilitation 1:53-61.
  • * Gualtieri, C.T. 1991. Buspirone for the behavior problems of patients with organic brain disorders. J Clin Psychopharmacol 11:280-281.
  • Gualtieri, C.T. 1991. Buspirone for the neurobehavioral sequelae of temporal lobe injuries. (UnPub)
  • * Arcia, E., and C.T. Gualtieri. (1994). Neurobehavioral performance of patients with closed head injury, attention deficit, and controls. Brain Injury, 8, 395-404.
  • Gualtieri, C.T. (1993). Pharmacological interventions for Cognitive and behavioral impairments. In Brain Injury Rehabilitation: Clinical Considerations. M.A.J. Finlayson, and S. Garner, editors. Williams & Wilkins, Baltimore. pp 264-278.
  • * Arcia, E., and C.T. Gualtieri. (1993). Association between patient report of symptoms after mild head injury and neurobehavioral performance. Brain Injury 7, 481-489.
  • Gualtieri, C.T. 1993. Traumatic Brain Injury. In Principles of Medical Psychiatry, 2nd Ed. A. Stoudemire, and B. Fogel, editors. Oxford University Press, New York. pp 517-538.
  • Blackerby,W.F., Gualtieri, C.T.,. (1991). Recent advances in neurobehavioral rehabilitation. NeuroRehabilitation 1, 53-61.
  • Gualtieri, C.T. (1991) The functional Neuroanatomy of Psychiatric Treatments. Psychiatric Clinics of North America 14, 113-124.
  • Gualtieri,C.T. (1995). The contribution of the frontal lobes to a theory of psychopathology. In Neuropsychiatry of Personality Disorders, Ed J.J.Ratey. Blackwell Science, Cambridge, 1995. pp 149-171.
  • * Gualtieri,C.T. (1995). The problem of mild brain injury. Neuropsychiatry, Neuropsychology and Behavioral Neurology, 8, 127-136.
  • Gualtieri,C.T. (1999). The treatment of mild brain injury. In Mild Brain Injury. N Varney, ed.
  • Gualtieri,C.T., Johnson,L.G. (1999). Problems in neuropsychiatric and neuropsychological assessment. Neurorehabilitation, in press.

Mental Retardation, Developmental Disabilities

  • Gualtieri, C.T. (1979) Psychiatry's disinterest in mental etardation. Psychiatric Opinion, 16, 26-30.
  • * Gualtieri, C.T., Koriath, J., Van Bourgondien, M. & Saleeby, N. (1983) Language disorders in children referred for psychiatric services. Journal American Academy Child Psychiatry, 22, 165-171.
  • * Gualtieri, C.T., Koriath, U. & Van Bourgondien, M.D. (1983)'Borderline' Children. Journal of Autism & Developmental Disabilities, 13, 67-72. Abstracted in Digest of Neurology & Psychiatry, 1983, LI, 210.
  • * Gualtieri, C.T. & Keppel, J.M. (1985) Psychopharmacology in the Mentally Retarded and a Few Related Issues. Psychopharmacology Bulletin, 21(2), 304-309.
  • Gualtieri, C.T. (1986) Fenfluramine & Autism: A Careful Re-Appraisal is in Order. Journal of Pediatrics, 108(3), 417-419.
  • Schroeder, S.R., Gualtieri, C.T. & Van Bourgondien, M.E. (1986) Autism. In: M. Hersen (ed) Pharmacological and Behavioral Treatment: An Integrative Approach. New York: Wiley, pp. 89-107.
  • Gualtieri, C.T., Evans, R.W. & Patterson, D.R. (1987) The Medical Treatment of Autistic People: Problems and Side Effects. In: E. Schopler & G. Mesibov (eds) Neurobiological Issues in Autism. New York: Plenum Press, 373-388.
  • Gualtieri, C.T. (1988) The Mental Health of Retarded People: A Solution, Obstacles to the Solution, and Resolution for the Problem. In: J. Stark, F. Menolascino, M. Albarelli & V. Gray (eds) Mental Health and Mental Retardation: Classification, Diagnosis, Treatment, Services. New York: Springer Verlag, pp. 173-188.
  • * Gualtieri, C.T. & Schroeder, S.R. (1989) Pharmacotherapy for Self-Injurious Behavior: Preliminary Tests of the D1 Hypothesis. Psychopharmacology Bulletin, 25, 364-371, 1989.
  • * Gualtieri,C.T. (1989) Differential Diagnosis of Self-Injurious Behavior. Psychopharmacology Bulletin, 25, 359-363.
  • Gualtieri, C.T. (1990) Neuropsychiatric Treatment for Autistic People. Post Graduate Advances in Autism, Forum Medicum. pp 1-11.
  • Chandler, M., Barnhill, L.J. & Gualtieri, C.T. (1991) Amantadine: A medical, Neuropsychological and Psychiatric Profile. In J Ratey, Mental Retardation: Developing Pharmacotherapies, American Psychiatric Press, Washington, pp 139-162.
  • Gualtieri,C.T. (1990) Pharmacotherapy for Self-Injurious Behavior: Preliminary Tests of the D1 Hypothesis. Progress Neuro-Psychopharmacol Biol, 14 (Suppl): S81-107.
  • * Gualtieri, C.T., Van Bourgondien, M.E., Hartz, C., Schopler, E., Marcus, L. (1980) A Pilot Study of Pyridoxine in Autistic Children. (Unpub).
  • * Gualtieri, C.T. 1991. The measurement of self-injurious behavior. J Neuropsych 3:s30-s34.
  • Ratey, J.J., and C.T. Gualtieri. 1991. Neuropsychiatry and mental retardation. In Mental Retardation: Developing Pharmacotherapies. J.J. Ratey, editor. American Psychiatric Press, Washington,D.C.. 1-18.
  • * Gualtieri, C.T. 1992. Psychopharmacology and the Fragile X Syndrome. In 1992 International Fragile X Conference Proceedings. R.J. Hagerman, and P. McKenzie, editors. Spectra Publishing Company, Dillon, Colorado. 167-178.
  • Gualtieri, C.T. (1992). New approaches to psychopharmacology for autistic people. Rev Ital Disturb Intell 5, 127-136. Italian translation, pp 165-174.
  • Casner,J., Weinheimer,B., Gualtieri,C.T. (1995). Naltrexone and self-injury: a retrospective population study. J Clin Psychopharm, 16, 389-394, 1996.
  • Fitzpatrick-Sanchez, S, Williams, D.E., Gualtieri, C.T., Raichman,J.A.. (1997). The effects of selective serotonergic reuptake inhibitors combined with behavioral treatment for self-injury associated with the Lesch-Nyhan syndrome. J Dev Phys Disabilities 10, 283-290, 1998.

Immunoreactivity

  • * Gualtieri, C.T., Hicks, R.E. & Mayo, J.P. (1984) Influence of Sex of Antecedent Siblings on the Human Sex Ratio. Life Sciences, 34, 1791-1794. Reprinted in 1984 in Obstetrics and Gynecology.
  • * Gualtieri, C.T. & Hicks, R.E. (1985) The Immunoreactive Theory of Selective Male Affliction. Behavior and Brain Sciences, 8(3), 427-477.
  • * Gualtieri, C.T., Mayo, J.P. & Hicks, R.E. (1985) ABO Incompatibility and Parity Effects of Perinatal Mortality. Social Biology, 32(1-2), 129-131.
  • * Gualtieri, C.T. & Hicks, R.E. (1986) Family Configuration and Family Size. Social Biology 33(1-2), 146-147.
  • Gualtieri, C.T. (1987) Fetal Antigenicity & Maternal Immunoreactivity in the Genesis of Mental Retardation. In: S.R. Schroeder (ed) Toxic Substances and Mental Retardation: Neurobehavioral Toxicity & Teratology, Washington, DC: AAMD Monograph Series, pp. 33-67.

Other Areas

  • Rosman, A.W. & Gualtieri, C.T. (1980) Therapeutics bibliography for clinical pharmacists: Psychiatry. American Journal Hospital Pharmacy, 37, 860-862.
  • * Gualtieri, C.T., Adams, A., Shen, C.D. & Loiselle, (1982) Minor physical anomalies in alcoholic and schizophrenic adults. American Journal of Psychiatry, 139, 640-642.
  • * Alhadeff, L., Gualtieri, C.T. & Lipton, M.A. (1984) Toxic Effects of Water Soluble Vitamins. Nutrition Reviews, 42, 33-40.
  • Gualtieri, C.T., Chandler, M.C. & Barnhill, L.J. (1990) Assessment of Physical Status: The Neuropsychiatric Examination of the Child. In: G. Burrows, B. Tonge & J. Werry (eds) Handbook of Studies in Child Psychiatry, Elsevier, Amsterdam

Presentations

  • American Psychiatric Association, 1981, 1982, 1985, 1986, 1990
  • American Psychological Association, 1980
  • American College of Neuropsychopharmacology, 1983, 1988
  • American Academy of Child Psychiatry, 1983, 1984, 1985, 1986, 1987
  • American Association of Psychiatric Services for Children, 1977, 1981
  • International Neuropsychological Society, 1987, 1989
  • New York Orton Society, 1984
  • International Conference on Psychiatry and the Law, 1984
  • National Conference on Research in Mental Retardation (Gatlinburg), 1986
  • American Association for Mental Deficiency, 1983
  • NIMH Consensus Conferences, 1979, 1984(2)
  • New Clinical Drug Evaluation Unit, 1983, 1986
  • President's Committee on Mental Retardation, 1985
  • World Psychiatric Association, 1986
  • National Association for the Dually Diagnosed, 1988
  • Cornelia de Lange Foundation (annually) 1988-